Overview
7,8-Dihydroxyflavone (7,8-DHF), also known as 7,8-Dihydroxyflavone, is a naturally occurring flavone found in plants such as Godmania aesculifolia, Tridax procumbens, and Primula species. It is a selective and potent agonist of the TrkB receptor, which is the primary signaling receptor for brain-derived neurotrophic factor (BDNF) . This compound has been extensively studied for its neuroprotective, cognitive-enhancing, and therapeutic potential in various neurological and psychiatric disorders.
Chemical Properties
- CAS Number: 38183-03-8
- Molecular Formula: C₁₅H₁₀O₄
- Molecular Weight: 254.24
- Purity: ≥98% (anhydrous basis)
- Appearance: Yellow powder
- Solubility: Soluble in DMSO (24 mg/mL), slightly soluble in water, and soluble in ethanol
Storage and Handling
- Storage Conditions:
- Powder form: Store at -20°C for 3 years
- In solvent: Store at -80°C for 2 years
- Handling:
- Wear protective gloves and lab coat during handling.
- Avoid inhalation, ingestion, or direct contact with skin or eyes.
- Keep in a cool, dry, and dark place to prevent degradation.
- Avoid repeated freezing and thawing to maintain stability
Mechanism of Action
7,8-DHF acts as a high-affinity agonist for the TrkB receptor, mimicking the effects of BDNF. It activates TrkB through receptor dimerization and autophosphorylation, leading to downstream signaling pathways such as MAPK, PI3K/Akt, and ERK1/1. This activation supports neuronal survival, synaptic plasticity, and neurogenesis . Additionally, 7,8-DHF has been shown to inhibit pyridoxal phosphatase, which may contribute to its cognitive-enhancing effects .
Applications and Therapeutic Potential
- Neuroprotection:
- 7,8-DHF supports the survival of nerve cells and prevents apoptosis.
- It has been shown to reverse cognitive deficits and synaptic plasticity impairments in animal models of Alzheimer’s disease and schizophrenia .
- Cognitive Enhancement:
- Improves memory, learning, and overall cognitive function.
- Enhances spatial memory and increases thin spine density in neuronal models .
- Antidepressant and Anxiolytic Effects:
- May alleviate depressive symptoms by modulating BDNF-dependent pathways.
- Rescues extinction deficits in mice with a history of traumatic stress .
- Treatment of Neurodegenerative Diseases:
- Demonstrates therapeutic potential in Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions.
- Reduces oxidative stress and inflammation in brain cells .
- Anti-inflammatory and Antioxidant Properties:
- Inhibits the release of inflammatory factors by blocking NF-κB.
- Exhibits antioxidant activity, protecting against neural inflammation and oxidative stress .
- Promotion of Nerve Regeneration:
- Stimulates nerve regeneration and synaptic plasticity, aiding in the recovery of brain function .
- Iron Homeostasis Regulation:
- Inhibits iron uptake in Salmonella cells, potentially enhancing the efficacy of antibiotics like colistin .
- Osteoarthritis Treatment:
- Activates the Nrf2/HO-1 signaling pathway, protecting against cartilage damage and osteoarthritis .
Safety and Usage
- Usage: For research purposes only. Not for clinical use.
- Toxicity: Chronic exposure to 7,8-DHF does not cause toxicity in various tissues and cell lines .
- DMSO Concentration: In cell culture, DMSO should be used at ≤0.3% to avoid cell toxicity. In animal studies, the final concentration of DMSO should be ≤5% .
Conclusion
7,8-Dihydroxyflavone is a versatile compound with broad applications in neuroscience and pharmacology. Its ability to activate TrkB, enhance cognitive function, and protect against neurodegenerative diseases makes it a promising candidate for further therapeutic development. Researchers are encouraged to explore its potential in both preclinical and clinical settings, while adhering to proper handling and storage guidelines to ensure its stability and efficacy.
